1. Peripheral Myelin Protein 22 gene duplication with atypical presentations: A new example of the wide spectrum of Charcot-Marie-Tooth 1A disease
- Author
-
Meriem Tazir, A.-M. Guennoc, Corinne Magdelaine, Laurence Richard, William Camu, Jean-Michel Vallat, Benoît Funalot, Philippe Corcia, Philippe Latour, Stéphane Mathis, Laurent Magy, and Julien Biberon
- Subjects
Adult ,congenital, hereditary, and neonatal diseases and abnormalities ,Pathology ,medicine.medical_specialty ,Peripheral myelin ,Recurrent nerve ,Disease ,Biology ,Charcot-Marie-Tooth Disease ,Gene Duplication ,Peripheral myelin protein 22 ,Gene duplication ,medicine ,Humans ,Child ,Pathological ,Genetics (clinical) ,Nerve biopsy ,medicine.diagnostic_test ,Middle Aged ,Pedigree ,Chromosome 17 (human) ,Neurology ,Pediatrics, Perinatology and Child Health ,Female ,Neurology (clinical) ,Myelin Proteins - Abstract
Charcot-Marie-Tooth type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP) are both autosomal-dominant disorders linked to peripheral myelin anomalies. CMT1A is associated with a Peripheral Myelin Protein 22 (PMP22) duplication, whereas HNPP is due to a PMP22 deletion on chromosome 17. In spite of this crucial difference, we report three observations of patients with the 1.4 megabase CMT1A duplication and atypical presentation (electrophysiological, clinical or pathological): a 10 year-old girl with tomaculous lesions on nerve biopsy; a 26 year-old woman with recurrent paresthesiae and block conduction on the electrophysiological study; a 46 year-old woman with transient recurrent nerve palsies mimicking HNPP. These observations highlight the wide spectrum of CMT1A and the overlap between CMT1A and HNPP (both linked to the PMP22 gene), and finally illustrate the complexity of the genotype-phenotype correlations in Charcot-Marie-Tooth diseases.
- Published
- 2014